TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.76+0.00 (+0.07%)
Close on Nov 17, 2026Market cap $34.21MP/E –Yield –
TELA Bio cash
Cash and short-term investments held at the end of each period.
TELA Bio's cash was $30.42M at Jun 30, 2026. For fiscal 2025 it was $50.85M, down 3.9% from the year before. The highest annual figure on record is $74.39M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.85M | -3.9% |
| FY2024 | Dec 31, 2024 | $52.94M | +12.6% |
| FY2023 | Dec 31, 2023 | $46.99M | +11.8% |
| FY2022 | Dec 31, 2022 | $42.02M | -4.4% |
| FY2021 | Dec 31, 2021 | $43.93M | -40.9% |
| FY2020 | Dec 31, 2020 | $74.39M | +36.3% |
| FY2019 | Dec 31, 2019 | $54.59M | +215.9% |
| FY2018 | Dec 31, 2018 | $17.28M | +52.3% |
| FY2017 | Dec 31, 2017 | $11.35M | +666.6% |
| FY2016 | Dec 31, 2016 | $1.48M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $30.42M | -13.0% |
| Q1 FY2026 | Mar 31, 2026 | $39.54M | -7.7% |
| Q4 FY2025 | Dec 31, 2025 | $50.85M | -3.9% |
| Q3 FY2025 | Sep 30, 2025 | $29.71M | +71.7% |
| Q2 FY2025 | Jun 30, 2025 | $34.98M | +32.0% |
| Q1 FY2025 | Mar 31, 2025 | $42.83M | +15.3% |
| Q4 FY2024 | Dec 31, 2024 | $52.94M | +12.6% |
| Q3 FY2024 | Sep 30, 2024 | $17.30M | -70.3% |
| Q2 FY2024 | Jun 30, 2024 | $26.50M | -59.4% |
| Q1 FY2024 | Mar 31, 2024 | $37.14M | +23.3% |
| Q4 FY2023 | Dec 31, 2023 | $46.99M | +11.8% |
| Q3 FY2023 | Sep 30, 2023 | $58.20M | +7.3% |
| Q2 FY2023 | Jun 30, 2023 | $65.27M | +135.4% |
| Q1 FY2023 | Mar 31, 2023 | $30.12M | -8.8% |
| Q4 FY2022 | Dec 31, 2022 | $42.02M | -4.4% |
| Q3 FY2022 | Sep 30, 2022 | $54.23M | +1.1% |
| Q2 FY2022 | Jun 30, 2022 | $27.73M | -54.0% |
| Q1 FY2022 | Mar 31, 2022 | $33.02M | -49.8% |
| Q4 FY2021 | Dec 31, 2021 | $43.93M | -40.9% |
| Q3 FY2021 | Sep 30, 2021 | $53.64M | -34.2% |
| Q2 FY2021 | Jun 30, 2021 | $60.29M | -29.5% |
| Q1 FY2021 | Mar 31, 2021 | $65.83M | +41.0% |
| Q4 FY2020 | Dec 31, 2020 | $74.39M | +36.3% |
| Q3 FY2020 | Sep 30, 2020 | $81.47M | +413.2% |
| Q2 FY2020 | Jun 30, 2020 | $85.47M | +806.2% |
| Q1 FY2020 | Mar 31, 2020 | $46.70M | +170.3% |
| Q4 FY2019 | Dec 31, 2019 | $54.59M | +2753.5% |
| Q2 FY2019 | Jun 30, 2019 | $15.87M | +39.9% |
| Q1 FY2019 | Mar 31, 2019 | $9.43M | +537.3% |
| Q4 FY2018 | Dec 31, 2018 | $17.28M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.91M | – |
| Q4 FY2017 | Dec 31, 2017 | $11.35M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.48M | – |
See a number that looks wrong?